Acelity Acquires Crawford Healthcare to Create the World’s

Most Expansive Wound Care Portfolio

Acelity L.P. Inc., the world’s largest wound care company, and Crawford Healthcare, a rapidly growing UK-based advanced wound care and dermatology company, today announced an agreement for Acelity to acquire Crawford and all of its assets. Terms of the agreement were not disclosed.

With the acquisition of Crawford, Acelity expands its portfolio of advanced wound dressings (AWD), further strengthening its position as the global leader in advanced wound healing.

Crawford Healthcare is a recognized leader in developing and commercializing innovative treatments for the care and repair of skin. Crawford’s wound dressing portfolio includes the market-leading superabsorbent KerraMax Care® range and KerraFoam and KerraCel in the foam and antimicrobial gelling fiber AWD categories, respectively.

Crawford’s advanced wound dressing lines complement Acelity’s existing AWD portfolio, which includes the market-leading collagen dressing PROMOGRAN PRISMA™ Matrix, as well as the TIELLE™ Dressing Family and ADAPTIC™ Dressings. This expanded line of advanced wound dressings combined with Acelity’s industry-leading negative pressure wound therapy platforms forms the world’s most expansive wound care portfolio. In addition to its commercial products, Acelity will acquire Crawford’s innovative R&D capabilities and manufacturing operations based in Cheshire, UK … read more